The neonatal immune imbalance suggests inhibiting the ROP-inducing cytokines IL-6, TNF-α, and IL-1β and immunomodulating neonatal immune cell types for an ROP-preventative treatment. This evidence concerns the gene TNF and retinopathy of prematurity.